Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) SHH

106.50

-4.12(-3.72%)

Updated at September 26 03:00PM

Currency In CNY

Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Address

No. 209, Chenfeng Road

Kunshan, 215300

China

Phone

86 512 5701 8310

Sector

Healthcare

Industry

Biotechnology

Employees

867

First IPO Date

January 23, 2020

Key Executives

NameTitlePayYear Born
Mr. Jisheng WuDirector & Deputy GM01965
Ms. Huiping LuExecutive Vice President & Director01967
Mr. Binhua LyuDeputy GM, EVice President of Chemistry & Director01979
Ms. Zeqi ShengChief Scientific Officer01964
Ms. Qingping GaoDeputy GM & Board Secretary01977
Shice ShaoAccounting Supervisor0N/A
Mr. Zelin ShengChairman of the Board & GM01960
Mr. Gang HuangChief Financial Officer & Deputy GM01971

Description

Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers small molecule and recombinant protein drugs for the treatment of liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, nasopharyngeal carcinomas, myelofibrosis, hemorrhage, and hepatobiliary diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China.